Alessandra Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.1M Buy
13,022
+257
+2% +$303K 10.6% 1
2026
Q2
$15.3M Sell
12,765
-25
-0.2% -$25.5K 10.84% 1
2026
Q1
$11.8M Sell
12,790
-231
-2% -$234K 10.03% 1
2025
Q4
$14M Buy
+13,021
New +$12.5M 12.44% 1

Other funds holding LLY

Alessandra Capital Management's LLY Position: Q3 2026 in Review

Alessandra Capital Management increased its Eli Lilly (LLY) stake by 2% in Q3 2026, buying an estimated $303K and bringing the position to 13,022 shares worth $15.1M. The position accounts for 10.6% of the portfolio, ranked #1.

Alessandra Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $15.3M in Q2 2026. 4,167 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Alessandra Capital Management held 13,022 shares of Eli Lilly worth $15.1M as of Q3 2026.
  • Alessandra Capital Management bought 257 Eli Lilly shares in Q3 2026, an estimated $303K.
  • Eli Lilly made up 10.6% of Alessandra Capital Management's portfolio in Q3 2026, its #1 holding.
  • Alessandra Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Alessandra Capital Management's Eli Lilly position peaked at $15.3M in Q2 2026.
  • 4,167 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Alessandra Capital Management's 13F filing for Q3 2026, filed 30 Oct 2026.